Disease burden of schizophrenia patients visiting a Chinese regional mental health centre

J Comp Eff Res. 2020 May;9(7):469-481. doi: 10.2217/cer-2019-0129. Epub 2020 Apr 17.

Abstract

Aim & methods: A decision-analytic model was constructed to simulate a real-world cohort of Chinese patients visiting a Chinese regional mental health center for long-term health outcomes and direct medical costs. Results: When compared with age and gender-matched general population, the Chinese patients with schizophrenia were associated with reduced overall survival by 20.6 years (27.6 vs 48.2 years) and reduced quality-adjusted life years (QALY) by 18.4 QALY (18.4 vs 36.8 QALY), respectively, and increased lifetime direct medical costs by about three-times (US$84,324 vs 33,387 as of 31 December 2017) on average. Conclusion: The burden of schizophrenia was mainly driven by the mortality associated with relapsed schizophrenia and direct medical costs for schizophrenia in local mental health rehabilitation institutes.

Keywords: QALY; burden; direct medical costs; life years; schizophrenia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • China
  • Cohort Studies
  • Cost of Illness
  • Costs and Cost Analysis
  • Female
  • Hospitals, Psychiatric / economics*
  • Humans
  • Life Expectancy
  • Male
  • Middle Aged
  • Models, Econometric
  • Quality-Adjusted Life Years
  • Schizophrenia / economics*
  • Schizophrenia / mortality